Valion Bio Inc (VBIO)

May 25, 2026

Valion Bio (VBIO) Stock Analysis Report | Financials & Insights - Benzinga

May 25, 2026

May 22, 2026

VBIO Stock Price, Quote & Chart | VALION BIO INC (NASDAQ:VBIO) - ChartMill

May 22, 2026

May 21, 2026

VBIO Price Today: Valion Bio, Inc. Stock Price, Quote & Chart | MEXC - MEXC

May 21, 2026

May 20, 2026

VBIO SEC FilingsValion Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 20, 2026

May 20, 2026

VBIO Stock Chart | VALION BIO INC (NASDAQ:VBIO) - ChartMill

May 20, 2026

May 19, 2026

Quest Diagnostics Declares Quarterly Cash Dividend - Weekly Voice

May 19, 2026

May 19, 2026

VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME - Barchart.com

May 19, 2026

May 17, 2026

Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work - MSN

May 17, 2026

May 15, 2026

Valion Bio Inc (VBIO-Q) Stock Price and News - The Globe and Mail

May 15, 2026

May 15, 2026

Valion Bio (VBIO) Reports Financial Position and Strategic Focus for 2026 - GuruFocus

May 15, 2026

May 14, 2026

Valion Bio's Velocity Bioworks Secures Exclusive Commercial Lice - GuruFocus

May 14, 2026

May 14, 2026

VBIO Technical Analysis & Stock Price Forecast - Intellectia AI

May 14, 2026

May 14, 2026

VBIO PE Ratio & Valuation, Is VBIO Overvalued - Intellectia AI

May 14, 2026

May 14, 2026

VBIO Should I Buy - Intellectia AI

May 14, 2026

May 14, 2026

VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - GuruFocus

May 14, 2026

May 14, 2026

Valion Bio Reports Q1 2026 Earnings and Strategic Outlook - Intellectia AI

May 14, 2026

May 14, 2026

Valion Bio Reports Q1 Results, Advances Entolimod Platform - TipRanks

May 14, 2026

May 14, 2026

Valion Bio, Inc. Common Stock Q1 2026 Earnings Call Transcript - MarketBeat

May 14, 2026

May 14, 2026

Valion Bio subsidiary secures exclusive NMR platform license By Investing.com - Investing.com South Africa

May 14, 2026

May 14, 2026

Valion Bio, Inc. 1Q 2026: Revenue $24K, Net loss $(6.20M), EPS $(2.23) — 10-Q Summary - TradingView

May 14, 2026

May 14, 2026

Valion Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026

May 14, 2026

[10-Q] Valion Bio, Inc. Quarterly Earnings Report - Stock Titan

May 14, 2026

May 14, 2026

Valion Bio subsidiary secures exclusive NMR platform license - Investing.com

May 14, 2026

May 14, 2026

Transcript : Valion Bio, Inc., Q1 2026 Earnings Call, May 14, 2026 - marketscreener.com

May 14, 2026

May 14, 2026

Valion Bio Q1 2026 Earnings Call: Complete Transcript - Benzinga

May 14, 2026

May 14, 2026

Valion Bio reports first quarter 2026 financial results - marketscreener.com

May 14, 2026

May 14, 2026

Valion Bio Reports First Quarter 2026 Financial Results - TradingView

May 14, 2026

May 14, 2026

Valion Bio (VBIO) widens Q1 2026 loss as it builds TLR5 and CDMO platform - Stock Titan

May 14, 2026

May 14, 2026

Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform - PR Newswire

May 14, 2026

May 14, 2026

Valion Bio Inc (VBIO) Earnings Calendar_Earnings Forecast_Financial Report and Earnings Call - Tiger Brokers

May 14, 2026

May 11, 2026

Valion Bio (VBIO.US) will release its earnings report after the market closes on May 14. - Moomoo

May 11, 2026

May 11, 2026

Valion Bio to Report First Quarter 2026 Financial Results on May 14, 2026 - Morningstar

May 11, 2026

May 08, 2026

3i group (TIVC) files amendment showing 9.99% holding and convertible exposure - Stock Titan

May 08, 2026

May 07, 2026

Number of shareholders of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

May 07, 2026

May 06, 2026

New San Antonio plant brings 45 jobs, backs radiation drug - Stock Titan

May 06, 2026

May 06, 2026

Valion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™ - Barchart

May 06, 2026

May 05, 2026

Valion Bio Appoints Melinda Lackey as General Counsel - The Globe and Mail

May 05, 2026

May 05, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 05, 2026

May 05, 2026

Valion Bio Names Melinda Lackey General Counsel as It Advances Immunotherapy Pipeline and Regulatory Strategy - citybiz

May 05, 2026

May 05, 2026

VBIO News | VALION BIO INC (NASDAQ:VBIO) - ChartMill

May 05, 2026

May 05, 2026

Valion Bio receives protocol for radiation syndrome drug study - Investing.com

May 05, 2026

May 05, 2026

Valion Bio receives protocol for radiation syndrome drug study By Investing.com - Investing.com Australia

May 05, 2026

May 05, 2026

Valion Bio receives first FDA-precedent study protocol from NIAID for Entolimod; federal agency to fully fund BLA-enabling in vivo program and co-navigate FDA submission - marketscreener.com

May 05, 2026

May 05, 2026

VALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSION - PR Newswire

May 05, 2026

May 04, 2026

Valion Bio Taps Legal-Science Hybrid to Drive Growth Strategy - BriefGlance

May 04, 2026

May 04, 2026

Valion Bio (VBIO) grants 45,000 stock options to general counsel - Stock Titan

May 04, 2026

May 04, 2026

Valion Bio (VBIO) General Counsel Melinda Lackey becomes reporting insider with Form 3 - Stock Titan

May 04, 2026

May 04, 2026

Valion Bio (Nasdaq: VBIO) hires Melinda Lackey as General Counsel - Stock Titan

May 04, 2026